Los Angeles Metropolitan Area
Award-winning sales leader with over 20 years of experience building high performance sales teams in the Oncology and Diagnostic healthcare industry. I am a change maker: my passion is to lead transformational teams built on trust and respect driven to deliver results. At Agendia, I am the Region Sales Director for the Western US. I am responsible for leading the West Region sales team to drive sales and market adoption of Agendia’s genomic assay for early-stage breast cancer. I believe in continuous improvement, challenging the status quo and placing my energy and passion in setting a vision and leading teams towards it. Established track record successful at building teams delivering excellence in business results, developing high-impact sales professionals, and effectively shaping a strong team culture. Accomplished strategic leader achieving multiple Performance Excellence and President Club awards.
Presidents Club Winner - 2025 Presidents Club Winner - 2024 Presidents Club Winner- 2023 West Region Sales Director responsible for leading a team of molecular oncology specialists to drive adoption of Agendia’s genomic assay at National Cancer Institutes, Academic Medical Centers and Community Oncology Clinics.
Erleada Brand Team leader responsible for developing, implementing and maintaining accountability with national oncology experts for the West Region. • Drive cross functional partnering between Brand Team, Commercial field teams, KAM’s and MSL’s to create strategies to execute Erleada Brand direction and regional tactical plans. • Manage components of the Speaker’s Bureau, both in programs, analyzing metrics and training of speakers. • Engaged in congress related engagement activities nationally, including supporting executive engagements and measuring any ongoing TL strategies and tactics. • Continually identifying, recruiting and developing KOL’s, to consistently build our TL base for the franchise and the brands. • Partner with brand marketing to gain key insights to develop Oncology External Expert Engagement strategy including Advisory boards, Community Councils and Steering committees.
Managing transition of CellSearch Business to Menarini Silicon BioSystems. Inclusive of training for sales and marketing teams, logistics for customer set up, sales ordering and customer service. New contracting processes for product and service agreements. Set KOL introduction meetings for Chief Commercial Officer and transitioned sales team to manage accounts. Manage strategic business activities with key customers: National Reference Labs, Academic Centers and Biotech Pharma Companies.
Dual Role: Market Development Manager: Oncology, Western U.S. & Canada | Strategic Marketing Organization driven to innovate within personalized medicine. Oncology capital equipment sales promoting cancer diagnostic systems (CellSearch®) Manage demand generation and pull through of oncology diagnostic equipment, reagents, and custom oncology lab services to top pharmaceutical and biotechnology companies, key academic institutions, NCI centers, oncology clinics, hospitals, and cancer researchers across the Western US and Canada. Exceeded business plans consecutively from 2012 through 2016 despite extremely challenging reimbursement coverage and lack of clinical guidelines for Circulating Tumor Cells (CTCs) by uncovering opportunities, collaborating with key internal resources and KOL’s to build value for my customers. Built consultative relationships with nationally recognized Key Opinion Leaders and C Suite Management at MD Anderson, USC, UCLA, Fred Hutch, UCSF, City of Hope and Vancouver Prostate Center leading to increased sales, Active partner with senior leadership involvement in gaining market access and reimbursement, Digital Marketing on Janssen Personalized Medicine website, sales forecasting and U.S and International contracting. Strategic Marketing role leading the Supply Chain and Distribution Strategy work stream for first Point of Care diagnostic. G&O’s include sales force development plan and creating sales force training plan. Launched SYLVANT® (Siltuximab) in 2014, the only FDA-approved therapy for the treatment of patients with Multicentric Castleman’s Disease. Leader: Nominated to J&J “Credo Action Team” committee focused in driving culture and engagement as voice for the national field sales team. -2014 Presidents Award Cup Winner -2013 Performance Sales Excellence Award Key Accounts: MD Anderson, USC, UCLA, UCSD, UCSF, City of Hope, Fred Hutch, Stanford, OHSU, BC Cancer